113 completed, 14 unknown, 6 not yet recruiting, 5 recruiting. 149 Phase 1, 18 Phase 2.
Follow Atorvastatin: new trials by email Literature Review of Atorvastatin trials Research Report on Atorvastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period. Allogeneic umbilical cord mesenchymal stem cell, Aspirin Enteric-coated Tablets & Atorvastatin Calcium - Cerebral Infarction | Phase 1 / Phase 2 | Suspended | Sclnow Biotechnology Co., Ltd. | 40 | 2026-12-31 | 2026-04-23 |
| A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult Volunteers Atorvastatin Calcium, Telmisartan - Drug-drug Interactions | Phase 1 | Not yet recruiting | Huons Co., Ltd. | 28 | 2026-09-01 | 2026-09-10 |
| Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease Atorvastatin, methylprednisolone (IVMP) - Thyroid Eye Disease, Graves Ophthalmopathy | Phase 1 | Not yet recruiting | Banu Aji Dibyasakti | 64 | 2026-08-30 | 2026-08-13 |
| A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants HRS-1301 Tablets, Atorvastatin Calcium Tablets, Midazolam oral solution - Hyperlipidemias | Phase 1 | Completed | Shandong Suncadia Medicine Co., Ltd. | 16 | 2026-06-08 | 2026-09-30 |
| Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity UBT251, Metformin hydrochloride, Warfarin Sodium - Drug Drug Interaction (DDI), Pharmacokinetics and Pharmacodynamics | Phase 1 | Recruiting | The United Bio-Technology (Hengqin) Co., Ltd. | 48 | 2026-05-27 | 2026-08-25 |
| PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC Axitinib, Toripalimab, Atorvastatin - Advanced Renal Cell Carcinoma (RCC), PTC | Phase 1 / Phase 2 | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 40 | 2026-05-14 | 2026-06-05 |
| A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018) Atorvastatin, Metformin, Ulonivirine - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 12 | 2026-04-29 | 2026-06-15 |
| A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants Elecoglipron, Atorvastatin, Rosuvastatin - Healthy Participants | Phase 1 | Active not recruiting | AstraZeneca | 48 | 2026-04-16 | 2026-08-28 |
| Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin Acetaminophen, Metformin, Warfarin - Overweight, Obesity | Phase 1 | Not yet recruiting | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 42 | 2026-04-08 | 2026-03-30 |
| Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers Simvastatin (10mg, 20mg, 40mg), Rosuvastatin (5mg, 20mg, 40mg), Atorvastatin (10mg, 20mg, 40mg) - Diabete Mellitus, Lipid Profile | Phase 1 | Not yet recruiting | Shaheed Benazir Bhutto University Sheringal Dir Upper | 100 | 2026-03-01 | 2026-01-30 |
| Prospective Management of Plaque Instability With Statins and Extra Folic Acid Atorvastatin plus folic acid, Atorvastatin - Carotid Atherosclerotic Plaque | Phase 1 / Phase 2 | Recruiting | Ruijin Hospital | 180 | 2026-03-01 | 2026-07-02 |
| [Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers] Rosuvastatin (5mg, 20mg, 40mg), Atorvastatin (10mg, 20mg, 40mg), Simvastatin (10mg, 20mg, 40m - Lipid Profile,Blood Pressure | Phase 1 | Not yet recruiting | Shaheed Benazir Bhutto University Sheringal Dir Upper | 100 | 2026-03-01 | 2026-02-05 |
| Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin Bempedoic acid, Ezetimibe, Atorvastatin - Healthy Subjects | Phase 1 | Completed | Daiichi Sankyo | 58 | 2025-12-09 | 2026-02-27 |
| to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban JP-1366 and clopidogrel, JP-1366 and aspirin, JP-1366 and atorvastatin - Drug Drug Interaction (DDI) | Phase 1 | Recruiting | Onconic Therapeutics Inc. | 96 | 2025-11-17 | 2025-12-04 |
| A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin Bempedoic acid, Ezetimibe, Atorvastatin - Healthy Subjects | Phase 1 | Completed | Daiichi Sankyo | 58 | 2025-10-28 | 2026-02-02 |
| A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants AZD5004, Rosuvastatin, Erythromycin - Healthy Participants | Phase 1 | Completed | AstraZeneca | 49 | 2025-05-06 | 2025-10-10 |
| Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin RAY1225, atorvastatin calcium tablet, Metformin Tablets - Obesity | Phase 1 | Active not recruiting | Guangdong Raynovent Biotech Co., Ltd | 32 | 2025-04-14 | 2026-01-23 |
| Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects Acetaminophen, Metformin, Warfarin - Type 2 Diabetes | Phase 1 | Completed | Fujian Shengdi Pharmaceutical Co., Ltd. | 57 | 2024-12-18 | 2025-06-22 |
| Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet Atorvastatin 10mg, Modification of dietary fat composition - Epilepsy, Dyslipidemia | Phase 1 / Phase 2 | Enrolling by invitation | Johns Hopkins University | 22 | 2024-10-04 | 2026-10-19 |
| A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects. Repaglinide, Atorvastatin, Digoxin - Healthy Adult Subject, Overweight Subject | Phase 1 | Unknown | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 30 | 2024-10-01 | 2024-09-23 |
Showing 20 of 149. Sign in to see all of them.
Hyperlipidemias (12) · Hypertension (8) · Obesity (7) · Dyslipidemias (6) · Hypercholesterolemia (6) · Diabetes Mellitus (5) · Diabetes Mellitus, Type 2 (5) · Essential Hypertension (4) · Overweight (4) · HIV Infections (3) · Acute Coronary Syndrome (2) · Atherosclerosis (2) · Cardiovascular Diseases (2) · Epilepsy (2) · Inflammation (2)
Chong Kun Dang Pharmaceutical (7) · Eli Lilly and Company (7) · Dr. Reddy's Laboratories Limited (6) · Boryung Pharmaceutical Co., Ltd (5) · HK inno.N Corporation (5) · GlaxoSmithKline (4) · Merck Sharp & Dohme LLC (4) · AstraZeneca (3) · Boehringer Ingelheim (3) · Novo Nordisk A/S (3) · Pfizer (3) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (3) · Ahn-Gook Pharmaceuticals Co.,Ltd (2) · Daiichi Sankyo (2) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (2)
United States (50) · South Korea (22) · China (18) · Germany (7) · Canada (4) · India (4) · Belgium (3) · Egypt (3) · United Kingdom (3) · Australia (2) · Jordan (2) · Pakistan (2) · Portugal (2) · Singapore (2) · Sweden (2)
Dr. Dharmesh Domadia, MD (2) · Mohammed Bader (2) · Adeep Puri, M.D. (1) · Alla Andreeva, PhD (1) · An-Hye Kim (1) · Andrew Spencer, MBChB, FRACP, PhD (1) · Ann Melvin, MD (1) · Autumn McRee, MD (1)
PMID 11877368, PMID 16514303, PMID 17118406, PMID 19201496, PMID 21067804, PMID 21412424, PMID 21765368, PMID 22140269, PMID 22209480, PMID 22288567, PMID 22448235, PMID 22606998, PMID 23727083, PMID 23991111, PMID 24070911, PMID 24214373, PMID 24452746, PMID 25016482, PMID 25103444, PMID 25175924, PMID 25771069, PMID 25942458, PMID 26426736, PMID 26768569, PMID 27923814, PMID 27956407, PMID 28163748, PMID 28349387, PMID 28357715, PMID 28475143, PMID 29549174, PMID 29765016, PMID 30683146, PMID 30686636, PMID 30781896, PMID 31591603, PMID 33309175, PMID 33485731, PMID 33792686, PMID 35105980, PMID 36743906, PMID 36743936, PMID 36829207, PMID 38402332, PMID 38918590, PMID 39502777, PMID 40088388, PMID 40120614, PMID 40569335, PMID 41072928
2014 (1), 2016 (1), 2019 (1), N01CN35159 (1), P30CA016672 (1), R01HL065176 (1), R01HL106041 (1), U01AI068632 (1)